Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles.
chronic lymphocytic leukemia
extracellular vesicles
mesenchymal stromal cells
microenvironment
prognostic factor
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
04
2020
accepted:
06
07
2020
entrez:
25
9
2020
pubmed:
26
9
2020
medline:
26
9
2020
Statut:
epublish
Résumé
Chronic lymphocytic leukemia (CLL) is caused by the accumulation of malignant B cells due to a defect in apoptosis and the presence of small population of proliferating cells principally in the lymph nodes. The abnormal survival of CLL B cells is explained by a plethora of supportive stimuli produced by the surrounding cells of the microenvironment, including follicular dendritic cells (FDCs), and mesenchymal stromal cells (MSCs). This crosstalk between malignant cells and normal cells can take place directly by cell-to-cell contact (assisted by adhesion molecules such as VLA-4 or CD100), indirectly by soluble factors (chemokines such as CXCL12, CXCL13, or CCL2) interacting with their receptors or by the exchange of material (protein, microRNAs or long non-coding RNAs) via extracellular vesicles. These different communication methods lead to different activation pathways (including BCR and NFκB pathways), gene expression modifications (chemokines, antiapoptotic protein increase, prognostic biomarkers), chemotaxis, homing in lymphoid tissues and survival of leukemic cells. In addition, these interactions are bidirectional, and CLL cells can manipulate the normal surrounding stromal cells in different ways to establish a supportive microenvironment. Here, we review this complex crosstalk between CLL cells and stromal cells, focusing on the different types of interactions, activated pathways, treatment strategies to disrupt this bidirectional communication, and the prognostic impact of these induced modifications.
Identifiants
pubmed: 32974152
doi: 10.3389/fonc.2020.01422
pmc: PMC7466743
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1422Informations de copyright
Copyright © 2020 Dubois, Crompot, Meuleman, Bron, Lagneaux and Stamatopoulos.
Références
Oncotarget. 2015 May 20;6(14):12048-60
pubmed: 25895128
Blood. 2011 Feb 3;117(5):1662-9
pubmed: 21115978
PLoS One. 2010 Jul 22;5(7):e11716
pubmed: 20661426
Transplantation. 1968 Mar;6(2):230-47
pubmed: 5654088
Nature. 2012 Sep 13;489(7415):309-12
pubmed: 22885698
Br J Haematol. 1996 Jan;92(1):97-103
pubmed: 8562418
Oncol Lett. 2018 Feb;15(2):1937-1942
pubmed: 29434893
Blood. 2011 Sep 29;118(13):3603-12
pubmed: 21803855
J Hematol Oncol. 2018 Jan 22;11(1):11
pubmed: 29357914
PLoS One. 2015 Oct 28;10(10):e0141429
pubmed: 26509439
Leukemia. 2008 Mar;22(3):585-92
pubmed: 18079738
Blood. 2007 Nov 1;110(9):3316-25
pubmed: 17652619
N Engl J Med. 2005 Feb 24;352(8):804-15
pubmed: 15728813
Blood. 2011 Jan 13;117(2):563-74
pubmed: 20940416
Leuk Lymphoma. 2018 Jun;59(6):1427-1438
pubmed: 28971726
J Immunol. 2004 Dec 1;173(11):6676-83
pubmed: 15557159
Leukemia. 2005 Jul;19(7):1216-23
pubmed: 15858619
Leuk Lymphoma. 2019 Dec;60(14):3461-3469
pubmed: 31352850
Exp Hematol. 2016 Jan;44(1):30-7.e1
pubmed: 26435347
Blood. 1999 Sep 15;94(6):1840-7
pubmed: 10477712
Blood. 2012 Jan 5;119(1):170-9
pubmed: 22086413
Blood. 2006 May 1;107(9):3584-92
pubmed: 16332969
Blood. 2010 Oct 21;116(16):2984-93
pubmed: 20606160
Cancer Discov. 2014 Dec;4(12):1448-65
pubmed: 25252690
Blood. 2019 Oct 24;134(17):1415-1429
pubmed: 31501154
PLoS One. 2015 Oct 21;10(10):e0140506
pubmed: 26488876
Semin Immunol. 2008 Feb;20(1):14-25
pubmed: 18261920
Cancer Res. 2009 Dec 15;69(24):9281-90
pubmed: 19934331
Br J Haematol. 2019 Jun;185(5):883-887
pubmed: 30873593
Blood. 1998 Apr 1;91(7):2387-96
pubmed: 9516138
Cancer Res. 2009 Apr 1;69(7):3121-30
pubmed: 19293181
Nat Rev Immunol. 2009 Sep;9(9):618-29
pubmed: 19644499
Blood. 1999 Dec 1;94(11):3658-67
pubmed: 10572077
Leukemia. 2016 Apr;30(4):833-43
pubmed: 26582643
Int Immunol. 2005 Jun;17(6):779-88
pubmed: 15908449
Blood. 2015 May 21;125(21):3297-305
pubmed: 25833959
N Engl J Med. 2000 Dec 28;343(26):1910-6
pubmed: 11136261
Sci Immunol. 2017 Jul 28;2(13):
pubmed: 28754746
Blood. 2009 Oct 29;114(18):3872-9
pubmed: 19717645
Blood. 2003 Mar 1;101(5):1962-9
pubmed: 12406905
Cell. 2012 Jul 6;150(1):194-206
pubmed: 22770220
Leukemia. 2015 Sep;29(9):1811-22
pubmed: 25917267
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80
pubmed: 20615965
Stem Cells Dev. 2014 Dec 15;23(24):2972-82
pubmed: 25055118
Semin Immunopathol. 2011 Sep;33(5):419-40
pubmed: 21174094
Blood. 2005 Aug 1;106(3):1012-20
pubmed: 15860672
Leuk Lymphoma. 2014 Apr;55(4):899-910
pubmed: 23837491
Blood. 2004 Jun 15;103(12):4389-95
pubmed: 14962897
Mol Med. 2015 Jan 09;21:123-33
pubmed: 25584781
J Hematol Oncol. 2017 May 19;10(1):112
pubmed: 28526063
Leuk Res. 2007 Jul;31(7):899-906
pubmed: 17241660
Nature. 1965 Oct 30;208(5009):500-2
pubmed: 5893802
Blood. 2015 Apr 2;125(14):2306-9
pubmed: 25838279
PLoS One. 2013 Dec 23;8(12):e83830
pubmed: 24376763
Nat Med. 1998 Jan;4(1):72-7
pubmed: 9427609
Biomed Mater. 2020 Apr 28;15(3):035016
pubmed: 32045893
Cancer Res. 2009 Aug 15;69(16):6387-95
pubmed: 19654311
Ann Hematol. 2011 Dec;90(12):1381-90
pubmed: 21465189
Mayo Clin Proc. 2004 Mar;79(3):318-25
pubmed: 15008605
Leuk Res. 2011 Jun;35(6):750-6
pubmed: 21093051
Oncotarget. 2018 Oct 12;9(80):35123-35140
pubmed: 30416684
Br J Haematol. 1967 May;13(3):269-88
pubmed: 6025241
Blood. 2014 Jul 24;124(4):546-54
pubmed: 24914134
Oncotarget. 2016 Jul 5;7(27):41031-41046
pubmed: 27127886
Haematologica. 2016 Mar;101(3):e99-102
pubmed: 26589908
PLoS One. 2011;6(8):e23758
pubmed: 21876768
Blood. 2009 Mar 26;113(13):3050-8
pubmed: 19074730
Blood. 2012 May 10;119(19):4467-75
pubmed: 22415752
Lancet Oncol. 2016 Jun;17(6):768-778
pubmed: 27178240
J Clin Invest. 2001 Feb;107(3):305-15
pubmed: 11160154
Blood. 2007 Dec 1;110(12):4012-21
pubmed: 17699742
Haematologica. 2006 Jan;91(1):56-63
pubmed: 16434371
Postepy Hig Med Dosw (Online). 2016 May 21;70(0):534-41
pubmed: 27333923
Br J Haematol. 2008 Mar;140(5):537-46
pubmed: 18275431
Haematologica. 2012 Apr;97(4):608-15
pubmed: 22058221
Mol Med. 2011;17(7-8):619-27
pubmed: 21519633
Haematologica. 2009 Jun;94(6):790-9
pubmed: 19377082
Oncotarget. 2015 Oct 27;6(33):34245-57
pubmed: 26413812
Cancer Cell. 2013 Jan 14;23(1):77-92
pubmed: 23328482
J Clin Invest. 2005 Mar;115(3):755-64
pubmed: 15711642
Blood. 2007 Jan 15;109(2):703-10
pubmed: 16973958
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Annu Rev Immunol. 2003;21:841-94
pubmed: 12615894
Blood. 2000 Oct 15;96(8):2655-63
pubmed: 11023495
Clin Chem. 2007 Oct;53(10):1757-66
pubmed: 17702857
Blood Cancer J. 2012 May;2(5):e73
pubmed: 22829975
Leuk Res. 2011 Nov;35(11):1432-5
pubmed: 21840049
J Immunol. 1998 Jun 1;160(11):5273-9
pubmed: 9605124
Transfus Med Hemother. 2010 Apr;37(2):75-83
pubmed: 20737049
Blood. 2001 May 1;97(9):2777-83
pubmed: 11313271
Leuk Lymphoma. 1995 Mar;17(1-2):127-33
pubmed: 7773149
Blood. 2011 Jan 20;117(3):882-9
pubmed: 21079155
Blood. 1996 May 15;87(10):4382-9
pubmed: 8639799
J Orthop Res. 1991 Sep;9(5):641-50
pubmed: 1870029
Blood. 2005 Jun 15;105(12):4813-9
pubmed: 15731179
Leuk Lymphoma. 2002 Mar;43(3):461-6
pubmed: 12002747
J Immunol. 1994 Oct 1;153(7):2951-61
pubmed: 7522246
Hematology. 2001;5(6):463-73
pubmed: 27419350
Leukemia. 2010 Dec;24(12):2063-71
pubmed: 20861921
Leuk Lymphoma. 2013 Aug;54(8):1826-30
pubmed: 23848063
Oncotarget. 2015 Dec 8;6(39):42130-49
pubmed: 26517523
Blood. 2014 Feb 13;123(7):1032-9
pubmed: 24277076
PLoS One. 2010 Dec 30;5(12):e15992
pubmed: 21209908
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Haematologica. 2010 Jul;95(7):1136-43
pubmed: 20145270
Oncotarget. 2015 Apr 10;6(10):7632-43
pubmed: 25544766
Drugs Today (Barc). 2016 Apr;52(4):249-60
pubmed: 27252989
Leukemia. 2002 Jan;16(1):30-5
pubmed: 11840260
Blood. 2002 Sep 1;100(5):1795-801
pubmed: 12176902
Mol Med Rep. 2015 Nov;12(5):7374-88
pubmed: 26458979
Br J Haematol. 2003 Feb;120(3):452-6
pubmed: 12580959
Leuk Lymphoma. 2012 Dec;53(12):2362-70
pubmed: 22616724
SLAS Discov. 2019 Sep;24(8):817-828
pubmed: 31345091
Nat Immunol. 2001 Dec;2(12):1126-32
pubmed: 11702067
Br J Haematol. 2009 Nov;147(4):471-83
pubmed: 19751240
J Immunol. 1998 Nov 1;161(9):4549-54
pubmed: 9794381
J Clin Invest. 1999 Jul;104(1):115-21
pubmed: 10393705
N Engl J Med. 2016 Jan 28;374(4):323-32
pubmed: 26641137
Oncogene. 2017 Jun 29;36(26):3651-3660
pubmed: 28192408
Haematologica. 2017 Sep;102(9):1594-1604
pubmed: 28596280
Ann Hematol. 2003 Aug;82(8):500-505
pubmed: 12783211
Front Med. 2019 Apr;13(2):138-151
pubmed: 30062557
J Cell Biol. 1978 Apr;77(1):148-64
pubmed: 659510
Leukemia. 2007 Jan;21(1):110-20
pubmed: 17024114
Int Rev Immunol. 2013 Aug;32(4):377-96
pubmed: 23886341
Haematologica. 2012 Feb;97(2):279-87
pubmed: 21993667
Stem Cells Dev. 2013 May 1;22(9):1329-41
pubmed: 23249221
Int J Mol Med. 2017 Apr;39(4):775-782
pubmed: 28290609
Leukemia. 2011 May;25(5):828-37
pubmed: 21372840
Leukemia. 2009 Jun;23(6):1159-63
pubmed: 19158830
Leukemia. 1999 Dec;13(12):1954-9
pubmed: 10602415
J Cell Sci. 2010 May 15;123(Pt 10):1603-11
pubmed: 20445011
Immunology. 2010 Aug;130(4):536-44
pubmed: 20331472
Blood. 2005 Sep 1;106(5):1824-30
pubmed: 15905192
PLoS One. 2013;8(3):e59756
pubmed: 23555770
Blood Rev. 2009 Jan;23(1):25-47
pubmed: 18599169
Cell Death Dis. 2019 Oct 28;10(11):817
pubmed: 31659149
Sci Transl Med. 2020 Jan 15;12(526):
pubmed: 31941829
Blood. 2015 Aug 27;126(9):1106-17
pubmed: 26100252
N Engl J Med. 2003 May 1;348(18):1764-75
pubmed: 12724482
Blood Cancer J. 2013 Sep 20;3:e149
pubmed: 24056719
Clin Cancer Res. 2009 Feb 1;15(3):995-1004
pubmed: 19188171
Blood. 2008 Aug 1;112(3):782-92
pubmed: 18487510
Haematologica. 2011 Mar;96(3):408-16
pubmed: 21134984
Leukemia. 2017 Jun;31(6):1340-1347
pubmed: 28074063
Exp Hematol. 2003 Mar;31(3):185-90
pubmed: 12644014
Haematologica. 2008 Oct;93(10):1575-9
pubmed: 18641015
Blood. 1992 Jun 1;79(11):2981-9
pubmed: 1375120
Blood. 2015 Nov 19;126(21):2404-14
pubmed: 26297738
Leuk Lymphoma. 1999 Nov;35(5-6):445-53
pubmed: 10609782
Cancer. 1985 Jul 15;56(2):328-32
pubmed: 3891066
Leuk Res. 2018 Mar;66:28-38
pubmed: 29353760
Blood. 2009 Nov 12;114(20):4441-50
pubmed: 19762485
J Exp Med. 1968 Feb 1;127(2):277-90
pubmed: 4169585
Blood. 2014 Mar 20;123(12):1810-7
pubmed: 24415539
J Med Microbiol. 1970 Feb;3(1):65-83
pubmed: 4915373
Blood. 2009 May 21;113(21):5237-45
pubmed: 19144983
Blood. 2004 Mar 15;103(6):2257-65
pubmed: 14630796
Nat Commun. 2018 Sep 21;9(1):3839
pubmed: 30242258
Blood. 2011 Jun 9;117(23):6287-96
pubmed: 21422473
J Exp Med. 2018 Feb 5;215(2):681-697
pubmed: 29301866
Cell Mol Neurobiol. 2016 Apr;36(3):301-12
pubmed: 27053351
FASEB J. 2020 Mar;34(3):3773-3791
pubmed: 31945226
Cancer Res. 2006 Jul 15;66(14):7158-66
pubmed: 16849562
Blood. 2014 Mar 6;123(10):1455-60
pubmed: 24394667
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
Blood. 1998 May 1;91(9):3379-89
pubmed: 9558396
Blood. 1993 Oct 15;82(8):2379-85
pubmed: 7691258
Br J Haematol. 2008 Oct;143(2):240-7
pubmed: 18710389
Oncotarget. 2015 Dec 29;6(42):44832-48
pubmed: 26540567
J Clin Oncol. 2014 Mar 20;32(9):897-904
pubmed: 24516016
Clin Chem. 2007 Feb;53(2):204-12
pubmed: 17158192
Blood. 2008 Jan 15;111(2):865-73
pubmed: 17959854
Neoplasia. 2017 Oct;19(10):762-771
pubmed: 28863345
J Exp Med. 1991 Jun 1;173(6):1297-304
pubmed: 1709674
Blood. 2010 Mar 4;115(9):1755-64
pubmed: 20018914
Leukemia. 2012 Jul;26(7):1576-83
pubmed: 22362000
Blood. 2009 Nov 26;114(23):4832-42
pubmed: 19789386
Blood. 2002 Apr 15;99(8):2977-84
pubmed: 11929789
Bull Acad Natl Med. 2002;186(7):1251-66; discussion 1266-8
pubmed: 12669665
Blood. 1999 Sep 15;94(6):1848-54
pubmed: 10477713
J Immunol. 1999 Apr 15;162(8):4455-63
pubmed: 10201982